Senate Bill S816

2017-2018 Legislative Session

Designates alpha-PVP, its salts, optical isomers and salts of optical isomers, as schedule I stimulant controlled substances

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions
Votes

co-Sponsors

2017-S816 (ACTIVE) - Details

See Assembly Version of this Bill:
A1959
Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Amd §3306, Pub Health L
Versions Introduced in Other Legislative Sessions:
2015-2016: S4743, A7336
2019-2020: S3006, A6942

2017-S816 (ACTIVE) - Summary

Designates alpha-PVP, its salts, optical isomers and salts of optical isomers, as schedule I stimulant controlled substances.

2017-S816 (ACTIVE) - Sponsor Memo

2017-S816 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                    816
 
                        2017-2018 Regular Sessions
 
                             I N  S E N A T E
 
                              January 5, 2017
                                ___________
 
 Introduced   by  Sens.  FUNKE,  GALLIVAN,  KENNEDY,  MARCHIONE,  MURPHY,
   RITCHIE, SERINO -- read twice and ordered printed, and when printed to
   be committed to the Committee on Health
 
 AN ACT to amend the  public  health  law,  in  relation  to  designating
   alpha-PVP as a schedule I stimulant controlled substance

   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision (f) of schedule I of section 3306 of the public
 health law is amended by adding a new paragraph 25 to read as follows:
   (25) ALPHA-PVP, ITS SALTS, OPTICAL ISOMERS AND SALTS OF OPTICAL  ISOM-
 ERS.
   §  2.  This  act shall take effect on the ninetieth day after it shall
 have become a law.
 
 
 
 
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD04223-01-7



              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.